1. Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents. Byonanebye DM; RESPOND Study Group.
   AIDS 2021. Abstract
    
2. Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium. Bansi-Matharu L, Phillips A, Oprea C, Grabmeier-Pfistershammer K, Günthard HF, De Wit S, Guaraldi G, Vehreschild JJ, Wit F, Law M, Wasmuth JC, Chkhartishvili N, d'Arminio Monforte A, Fontas E, Vesterbacka J, Miro JM, Castagna A, Stephan C, Llibre JM, Neesgaard B, Greenberg L, Smith C, Kirk O, Duvivier C, Dragovic G, Lundgren J, Dedes N, Knudsen A, Gallant J, Vannappagari V, Peters L, Elbirt D, Sarcletti M, Braun DL, Necsoi C, Mussini C, Muccini C, Bolokadze N, Hoy J, Mocroft A, Ryom L.
   Lancet HIV. 2021:S2352-3018(21)00163-6. Epub ahead of print. Abstract
    

IN PRESS